28.
Vitreoretinal Interface and Retinal Vein Occlusion –
a New Aspect of a Well-known Disease?
Lars-Olof Hattenbach, K. Köhler, F. Höhn, A. Mirshahi (Ludwigshafen)
Current data suggest that the intravitreal administration of antiangiogenic agents or steroids
has the potential to improve major clinical outcomes in branch or central retinal vein occlusion.
However, the task of determining the appropriate therapeutic approach in retinal vein
occlusion is complicated, because severity of the disease and intervals between the patients’
first symptoms and presentation differ widely. Vision loss is related to the extent of macular
damage from intraretinal edema, hemorrhage or capillary non-perfusion. Moreover, there is
increasing evidence that the status of the posterior vitreous may have an impact on the visual
prognosis in retinal vein occlusion. Several clinical studies on the management of retinal vein
occlusion are reviewed to determine prognostic factors. Moreover, we report on the evaluation
of the posterior vitreoretinal interface with OCT scan and contact B-scan ultrasound in retinal vein occlusion patients who
underwent treatment with intravitreal drugs.